title: Porcine rubulavirus LPMV RNA persists in the central nervous system of pigs after recovery from acute infection.
abstract: In order to study persistence of the porcine rubulavirus LPMV, we examined tissue samples collected from pigs 53 days after experimental infection. These pigs survived the initial infection and could clinically be considered to have recovered from the infection. Two of the pigs used in this study were chemically immunosuppressed during the last 4 days before necropsy. No infectious virus or viral antigen could be detected in any tissue using standard methods for virus isolation and detection. However, the presence of viral genomic RNA and mRNA could be demonstrated in the mid brain of the convalescent pig using an optimised RT-nested PCR. Mid brain, forebrain and lung were all shown to contain LPMV RNA in the immunosuppressed convalescent pigs. In addition we examined the P-gene editing in the recovered pigs and conclude that the viral genome is transcriptionally active in these pigs. The relevance of the persistence of LPMV for maintenance and spread within and/or between pig populations is discussed.
authors.affiliation: Department of Veterinary Microbiology, Swedish University of Agricultural Sciences, Biomedical Centre, Uppsala.
authors.forename: A C
authors.initials: AC
authors.lastname: Wiman
authors.forename: B
authors.initials: B
authors.lastname: Hjertner
authors.forename: T
authors.initials: T
authors.lastname: Linné
authors.forename: B
authors.initials: B
authors.lastname: Herron
authors.forename: G
authors.initials: G
authors.lastname: Allan
authors.forename: F
authors.initials: F
authors.lastname: McNeilly
authors.forename: B
authors.initials: B
authors.lastname: Adair
authors.forename: J
authors.initials: J
authors.lastname: Moreno-López
authors.forename: M
authors.initials: M
authors.lastname: Berg
mesh_terms: D000208:Acute Disease; D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D001921:Brain / Q000473:pathology / Q000821:virology*; D003289:Convalescence; D003520:Cyclophosphamide / Q000494:pharmacology; D005814:Genes, Viral / Q000235:genetics; D016679:Genome, Viral; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008168:Lung / Q000821:virology; D017393:RNA Editing / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D012367:RNA, Viral / Q000032:analysis*; D019213:Rubulavirus / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D019351:Rubulavirus Infections / Q000473:pathology / Q000635:transmission / Q000821:virology*; D013552:Swine; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000235:genetics*
chemical_list: D000956:Antigens, Viral; D007166:Immunosuppressive Agents; C106937:L protein, porcine rubulavirus; D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; D003520:Cyclophosphamide